Allosterix Pharmaceuticals
Developing Highly Selective Peptide-based Inhibitors
Company Overview
Snapshot
Founded in July 2007 by Ariel Solomon and Omer Vunsch, Allosterix Pharmaceuticals operates with 1–10 employees. The company focuses on developing highly selective peptide-based inhibitors using a patent-pending technology for locating allosteric sites and peptidic drug design. Allosterix Pharmaceuticals is currently part of Silicon Slopes, a nonprofit organization and startup greenhouse.
Business overview
Allosterix Pharmaceuticals is a Health Tech & Life Sciences company specializing in drug discovery and development within the pharmaceutical sector. The company's core technology involves a patent-pending approach to drug design that creates inhibitors based on the principles of allostery. This method targets allosteric sites in nonconserved regions of enzymes, aiming for greater specificity and reduced side effects compared to traditional enzymatic inhibition strategies. Allosterix Pharmaceuticals serves the pharmaceutical and laboratory markets, focusing on developing novel therapeutic solutions.
Log in to access full profile ›Company Intelligence Q&A
- What is Allosterix Pharmaceuticals' core technology?
- Allosterix Pharmaceuticals has developed a patent-pending technology for locating allosteric sites and peptidic drug design, creating inhibitors based on the principles of allostery for enhanced specificity.
- Who are the founders of Allosterix Pharmaceuticals?
- Allosterix Pharmaceuticals was co-founded by Ariel Solomon, who serves as CEO, and Omer Vunsch.
- What is the primary advantage of Allosterix Pharmaceuticals' drug design approach?
- The company's approach to drug design offers greater specificity, as selectivity is inherent in each peptidic inhibitor, leading to a low incidence of unwanted side effects or toxicity.
- In what year was Allosterix Pharmaceuticals founded?
- Allosterix Pharmaceuticals was founded in July 2007.
- Where is Allosterix Pharmaceuticals currently based?
- Allosterix Pharmaceuticals LLC is currently part of Silicon Slopes, a nonprofit organization and startup greenhouse located in Lehi, Utah, USA.